Carcinoid tumour.

PubWeight™: 4.52‹?› | Rank: Top 1%

🔗 View Article (PMID 9737302)

Published in Lancet on September 05, 1998

Authors

M E Caplin1, J R Buscombe, A J Hilson, A L Jones, A F Watkinson, A K Burroughs

Author Affiliations

1: Neuroendocrine Tumour Group and Clinic, Royal Free Hospital, London, UK. caplin@rfhsm.ac.uk

Associated clinical trials:

Natural History of Familial Carcinoid Tumor | NCT00646022

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET) | NCT03870399

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression (POLNETS_PRRT) | NCT04029428

Articles citing this

Updated population-based review of carcinoid tumors. Ann Surg (2004) 3.21

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14

Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg (2004) 1.49

Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol (2008) 1.48

Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs). Surgery (2015) 1.39

Primary hepatic carcinoid: a case report and literature review. World J Gastroenterol (2009) 1.28

Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21

Primary carcinoid tumors of the liver. World J Surg Oncol (2008) 1.14

99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience. Eur J Nucl Med Mol Imaging (2006) 1.13

Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol (2009) 1.12

Carcinoid tumour. Lancet (1998) 1.05

7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg (2007) 0.97

Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. Fam Cancer (2007) 0.90

Current advance in small bowel tumors. Clin Endosc (2011) 0.89

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate. Eur J Nucl Med Mol Imaging (2008) 0.88

Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors. Int J Colorectal Dis (2008) 0.87

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization. BMC Cancer (2013) 0.87

The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine tumors (GEP-NETs), compared to FSE T2 and FFE T1 weighted image after i.v. Gd-EOB-DTPA contrast enhancement. Med Sci Monit (2012) 0.85

Primary hepatic carcinoid tumor. World J Surg Oncol (2011) 0.85

Neuroendocrine tumor metastatic to the orbit treated with radiotherapy. World J Gastrointest Oncol (2013) 0.84

Carcinoid and neuroendocrine tumors of the colon and rectum. Clin Colon Rectal Surg (2006) 0.83

Neuroendocrine carcinoma arising in soft tissue: three case reports and literature review. World J Surg Oncol (2007) 0.82

Primary hepatic carcinoid tumor: case report and literature review. Einstein (Sao Paulo) (2014) 0.81

Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin. Br J Cancer (2003) 0.81

Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews. JMIR Res Protoc (2013) 0.81

Primary Neuroendocrine Tumor of Liver (Rare Tumor of Liver). Iran J Cancer Prev (2015) 0.80

Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol (2005) 0.80

Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes. Mol Cell Proteomics (2009) 0.78

Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. J Clin Endocrinol Metab (2008) 0.78

Gastric polyps and protruding type gastric cancer. Clin Endosc (2013) 0.77

Primary lung carcinoid, a rare cause of paraparesis: report of a case and review of the literature. J Thorac Dis (2012) 0.77

A stepwise approach to the management of metastatic midgut carcinoid tumor. Nat Rev Clin Oncol (2009) 0.76

Carcinoid tumour. Lancet (1998) 0.75

An overview of the surgical management of hepatic neuroendocrine metastases. Indian J Surg Oncol (2012) 0.75

Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review. J Orthop (2014) 0.75

Carcinoid tumour. Lancet (1998) 0.75

Clinical features of gastroenteropancreatic tumours. Prz Gastroenterol (2015) 0.75

Rectal Neuroendocrine Tumor G1 with a Solitary Hepatic Metastatic Lesion. Intern Med (2017) 0.75

Post-surgical surveillance of locally advanced ileal carcinoids found by routine ileal intubation during screening colonoscopy: a case series. J Med Case Rep (2014) 0.75

Selective Internal Radiation Therapy in Metastatic Carcinoma of the Colon: A Story of Nonintegrated Care? World J Nucl Med (2016) 0.75

[Immunohistochemical evaluation of somatostatin receptor subtypes in surgical pathology specimens of neuroendocrine tumors]. Pathologe (2010) 0.75

Articles by these authors

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11

Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98

Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology (1974) 3.97

Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75

Infectious complications of subcutaneous interleukin-2 and interferon-alpha. Lancet (1992) 2.65

Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver. J Lipid Res (1967) 2.58

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50

Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39

Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35

Hypertrophy of the agranular endoplasmic reticulum in hamster liver induced by phenobarbital (with a review on the functions of this organelle in liver). J Histochem Cytochem (1966) 2.31

The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29

An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22

Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22

Nucleotide sequence analysis of a transposon (Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other gram-negative bacteria. J Bacteriol (1993) 2.18

Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13

Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10

Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res (1972) 2.07

Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00

A prospective evaluation of the clinical utility of the lower-extremity injury-severity scores. J Bone Joint Surg Am (2001) 1.99

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98

Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A (1977) 1.97

Autoregulation of tubulin synthesis in hepatocytes and fibroblasts. J Cell Biol (1985) 1.95

"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95

Interaction of insulin with Pseudomonas pseudomallei. Infect Immun (1993) 1.95

Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92

Distribution of tetracycline resistance genes and transposons among phylloplane bacteria in Michigan apple orchards. Appl Environ Microbiol (1999) 1.91

A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90

Evidence for a vesicular transport mechanism in hepatocytes for biliary secretion of immunoglobulin A. Science (1980) 1.89

An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87

Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86

Medical audit of the care of patients with epilepsy in one group practice. J R Coll Gen Pract (1980) 1.84

Interobserver agreement in the classification of open fractures of the tibia. The results of a survey of two hundred and forty-five orthopaedic surgeons. J Bone Joint Surg Am (1994) 1.83

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78

A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76

Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75

Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72

An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical location. Br J Cancer (1999) 1.68

Cold pressor test in detection of coronary heart-disease and cardiomyopathy using technetium-99m gated blood-pool imaging. Lancet (1979) 1.65

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63

Community-based injury prevention interventions. Future Child (2000) 1.63

Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62

Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61

Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60

Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet (1999) 1.59

Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57

Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56

Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52

Autoradiographic localization of the sites of uptake, cellular transport, and catabolism of low density lipoproteins in the liver of normal and estrogen-treated rats. Proc Natl Acad Sci U S A (1981) 1.51

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Eur J Cancer (1990) 1.47

Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47

Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47

Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46

Autoregulation of tubulin synthesis in enucleated cells. Nature (1985) 1.45

Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation (1995) 1.45

Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45

Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet (1999) 1.45

Doctors' knowledge of the appropriate use and route of administration of antidotes in the management of recreational drug toxicity. Emerg Med J (2008) 1.45

Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens. Gut (1999) 1.44

Case report: migration and shortening of a self-expanding metallic stent complicating the treatment of malignant superior vena cava stenosis. Clin Radiol (1996) 1.42

Bile secretory apparatus: evidence for a vesicular transport mechanism for proteins in the rat, using horseradish peroxidase and [125I]insulin. Gastroenterology (1980) 1.42

Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Clin Radiol (1998) 1.41

Complete nucleotide sequence of ubiquitous plasmid pEA29 from Erwinia amylovora strain Ea88: gene organization and intraspecies variation. Appl Environ Microbiol (2000) 1.41

Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40

Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis. J Cyst Fibros (2011) 1.40

Celebrity's death from cancer resulted in increased calls to CancerBACUP. BMJ (1998) 1.40

The elimination of treatment predictability in double-blind studies. Br J Clin Pharmacol (1985) 1.40

Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40

Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39

Training of staff for the delivery of PET/CT services in the UK. Nucl Med Commun (2006) 1.39

Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39

Scintigraphic evidence of abnormal ureteric peristalsis following urological surgery. Br J Urol (1994) 1.39

Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin Radiol (1998) 1.38

LeVeen shunt with wandering tip. Lancet (1991) 1.36

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest (1993) 1.36

Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35

Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther (2009) 1.35

The aesthetics of colour. Perception (1982) 1.34

Isolation and characterization of five Erwinia amylovora bacteriophages and assessment of phage resistance in strains of Erwinia amylovora. Appl Environ Microbiol (2001) 1.33

An electron microscopic study of lipoprotein production and release by the isolated perfused rat liver. Proc Soc Exp Biol Med (1966) 1.33

Increased cholesterol biosynthesis following phenobarbital induced hypertrophy of agranular endoplasmic reticulum in liver. Proc Soc Exp Biol Med (1965) 1.32

The ultrastructure of endocrine glands. Recent Prog Horm Res (1969) 1.31

High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30

Controversies in the management of bleeding esophageal varices (1) N Engl J Med (1989) 1.30

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29

Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27

Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (1991) 1.27

Review of the radiation exposure of the UK population. J Radiol Prot (2005) 1.27

Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res (1998) 1.26

Magnetic resonance imaging of meniscal and cruciate injuries of the knee. J Bone Joint Surg Br (1991) 1.26

Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant (2007) 1.25

Entry of insulin into human cultured lymphocytes: electron microscope autoradiographic analysis. Science (1978) 1.25

Endoscopic extraction of bile duct stones: management related to stone size. Gut (1993) 1.24

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat Med (1996) 1.24

The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat (1994) 1.24